Patient Access to Innovation: Biopharmaceuticals, 4th Hurdles and Socioeconomic Issues

Journal of Commercial Biotechnology - United Kingdom
doi 10.5912/jcb396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

thinkBiotech, LLC

Related search

Structural Biological Approach to Biopharmaceuticals

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Bringing Patient-Centered Innovation to Patient Education & Counseling

Patient Education and Counseling
Medicine
2018English

Enhancing Developing Country Access to Eco-Innovation

OECD Environment Working Papers
2010English

Seismic Access Issues

Alberta Law Review
2002English

Biopharmaceuticals: Definition and Regulation

English

Measuring Police Innovation: Issues and Measurement

Policing
Forensic MedicinePathologyLawPublic Administration
2000English

Regional Competitiveness Response to Innovation Changes: Issues of Evaluation

Journal of Urban and Regional Analysis
Urban Studies
2019English

Access to Self-Management Education, Conservative Treatment and Surgery for Arthritis According to Socioeconomic Status

Best Practice and Research in Clinical Rheumatology
MedicineRheumatology
2012English

Php257 - An Analysis and Feasibility Assessment of Indication-Specific Pricing as a Means to Improve Patient Access to Medicines and Reinforce Incentives for Innovation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy